Davor Frleta, Ph.D.
Affiliations: | 2004 | Dartmouth College, Hanover, NH, United States |
Area:
Immunology, Cell BiologyGoogle:
"Davor Frleta"Parents
Sign in to add mentorJames D. Gorham | grad student | 2004 | Dartmouth | |
(Regulation of dendritic cell biology in vitro and in vivo with biological response modifiers.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Lin W, Singh V, Springer R, et al. (2023) Human CD4 cytotoxic T lymphocytes mediate potent tumor control in humanized immune system mice. Communications Biology. 6: 447 |
Wei J, Montalvo-Ortiz W, Yu L, et al. (2022) CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma models. Science Translational Medicine. 14: eabn1082 |
Frleta D, Yu CI, Klechevsky E, et al. (2009) Influenza virus and poly(I:C) inhibit MHC class I-restricted presentation of cell-associated antigens derived from infected dead cells captured by human dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 182: 2766-76 |
Frleta D, O'Brien M, Haynes B, et al. (2009) P10-05. Suppression of human dendritic cell function during acute HIV infection Retrovirology. 6 |
Frleta D, Noelle RJ, Wade WF. (2003) CD40-mediated up-regulation of Toll-like receptor 4-MD2 complex on the surface of murine dendritic cells. Journal of Leukocyte Biology. 74: 1064-73 |
Frleta D, Lin JT, Quezada SA, et al. (2003) Distinctive maturation of in vitro versus in vivo anti-CD40 mAb-matured dendritic cells in mice. Journal of Immunotherapy (Hagerstown, Md. : 1997). 26: 72-84 |
Frleta D, Demian D, Wade WF. (2001) Class II-targeted antigen is superior to CD40-targeted antigen at stimulating humoral responses in vivo International Immunopharmacology. 1: 265-275 |